These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5845685)

  • 21. [Animal experimental production of bone marrow fibroses using repeated injections of foreign protein and their medicamentous influencing through azathioprine and prednisolone].
    Hauswaldt C; Hunseein W; Kaboth U; Lattermann W
    Verh Dtsch Ges Inn Med; 1969; 75():718-20. PubMed ID: 5401616
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis.
    Andrieux J; Roche-Lestienne C; Geffroy S; Desterke C; Grardel N; Plantier I; Selleslag D; Demory JL; Laï JL; Leleu X; Le Bousse-Kerdiles C; Vandenberghe P
    Cancer Genet Cytogenet; 2007 Oct; 178(1):11-6. PubMed ID: 17889703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The bone changes in myelofibrosis and osteomyelofibrosis].
    PAPAGEORGIOU A
    Acta Haematol; 1962; 28():201-21. PubMed ID: 13941279
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic osteosclerosis associated with primary bone marrow B-cell lymphoma.
    Ozaki S; Iima T; Sekimoto E; Shibata H; Shigekiyo T; Higuchi Y; Hirose T
    EJHaem; 2023 May; 4(2):483-487. PubMed ID: 37206285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study.
    Schmidt A; Blanchet O; Dib M; Baslé MF; Ifrah N; Chappard D
    Eur J Haematol; 2007 Jun; 78(6):500-9. PubMed ID: 17419743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extranodal non-Hodgkin's lymphoma associated with systemic bone metastasis and secondary myelofibrosis].
    Kasahara K; Takahashi T; Oka T; Yamamoto M; Sirata T; Idogawa M; Naeshiro M; Hayashi T; Adachi M; Hinoda Y; Imai K
    Rinsho Ketsueki; 1998 Dec; 39(12):1180-4. PubMed ID: 10028851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of myelofibrosis-derived fibroblasts.
    Castro-Malaspina H; Jhanwar SC
    Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contributions to the study of osteomyelosclerosis].
    TUDORANU G; POPA G; DOBRESCU G
    Med Interna (Bucur); 1963 Jan; 15():31-7. PubMed ID: 13994709
    [No Abstract]   [Full Text] [Related]  

  • 30. [Osteomyelosclerosis of the Baumgarten type].
    Ruberti A; Biolcati Rinaldi A; Mirizio A; Wallini A
    Arcisp S Anna Ferrara; 1967; 20(1):45-76. PubMed ID: 5599303
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated TNF-alpha and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis.
    Jurisic V; Terzic T; Pavlovic S; Colovic N; Colovic M
    Pathol Res Pract; 2008; 204(2):129-32. PubMed ID: 17976926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: demonstration of a graft-versus-myelofibrosis effect.
    Cervantes F; Rovira M; Urbano-Ispizua A; Rozman M; Carreras E; Montserrat E
    Bone Marrow Transplant; 2000 Sep; 26(6):697-9. PubMed ID: 11035377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contribution to the study of idiopathic osteomyelosclerosis].
    Chiariotti F; Moda S
    Minerva Med; 1967 Oct; 58(83):3526-35. PubMed ID: 6061053
    [No Abstract]   [Full Text] [Related]  

  • 34. Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.
    Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A
    Best Pract Res Clin Haematol; 2006; 19(3):495-517. PubMed ID: 16781486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone and bone-marrow blood flow in chronic granulocytic leukemia and primary myelofibrosis.
    Lahtinen R; Lahtinen T; Romppanen T
    J Nucl Med; 1982 Mar; 23(3):218-24. PubMed ID: 6950031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of MRI in the valuation of disorders involving the bone marrow].
    Gualdi GF; Di Biasi C; Serafini G; Casciani E
    Clin Ter; 1997 Sep; 148(9):407-17. PubMed ID: 9410664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laboratory diagnosis of idiopathic myelofibrosis. Review of the literature and presentation of 15 cases].
    Milanesi B; Pirali F
    Minerva Med; 1981 Sep; 72(34):2265-72. PubMed ID: 7290453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leukocyte alkaline phosphatase and blood diseases (differential diagnostic and prognostic significance)].
    KEISER G; ALSLEBEN U
    Schweiz Med Wochenschr; 1963 Jan; 93():1-7. PubMed ID: 14031703
    [No Abstract]   [Full Text] [Related]  

  • 39. [Idiopathic myelofibrosis transformed to acute myelomonocytic leukemia associated with non-Hodgkin's lymphoma].
    Kato M; Umeda M; Kosuge T; Anno S; Tsukahara T; Shirai T
    Rinsho Ketsueki; 1994 Jun; 35(6):581-7. PubMed ID: 8078193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A CASE OF PRIMARY OSTEOMYELOCLEROSIS].
    KOSINSKI W; ZOLNIERCZYK J
    Wiad Lek; 1965 Apr; 18():597-601. PubMed ID: 14347482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.